Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP957978.RAqYgSYJhk-T9A4ihZHkmggeE1BHJ5gF7nY-eti-NK0zc130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP957978.RAqYgSYJhk-T9A4ihZHkmggeE1BHJ5gF7nY-eti-NK0zc130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP957978.RAqYgSYJhk-T9A4ihZHkmggeE1BHJ5gF7nY-eti-NK0zc130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP957978.RAqYgSYJhk-T9A4ihZHkmggeE1BHJ5gF7nY-eti-NK0zc130_provenance.
- NP957978.RAqYgSYJhk-T9A4ihZHkmggeE1BHJ5gF7nY-eti-NK0zc130_assertion description "[We also found that Ik6 variant and CRLF2 overexpression had an important role in dictating the prognosis of Ph-negative patients, which may be useful markers in guiding the treatment of ALL in the future, with tyrosine kinase inhibitors on the other hand reversing the fate of Ph-positive ALL patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP957978.RAqYgSYJhk-T9A4ihZHkmggeE1BHJ5gF7nY-eti-NK0zc130_provenance.
- NP957978.RAqYgSYJhk-T9A4ihZHkmggeE1BHJ5gF7nY-eti-NK0zc130_assertion evidence source_evidence_literature NP957978.RAqYgSYJhk-T9A4ihZHkmggeE1BHJ5gF7nY-eti-NK0zc130_provenance.
- NP957978.RAqYgSYJhk-T9A4ihZHkmggeE1BHJ5gF7nY-eti-NK0zc130_assertion SIO_000772 22297722 NP957978.RAqYgSYJhk-T9A4ihZHkmggeE1BHJ5gF7nY-eti-NK0zc130_provenance.
- NP957978.RAqYgSYJhk-T9A4ihZHkmggeE1BHJ5gF7nY-eti-NK0zc130_assertion wasDerivedFrom befree-2016 NP957978.RAqYgSYJhk-T9A4ihZHkmggeE1BHJ5gF7nY-eti-NK0zc130_provenance.
- NP957978.RAqYgSYJhk-T9A4ihZHkmggeE1BHJ5gF7nY-eti-NK0zc130_assertion wasGeneratedBy ECO_0000203 NP957978.RAqYgSYJhk-T9A4ihZHkmggeE1BHJ5gF7nY-eti-NK0zc130_provenance.
- befree-2016 importedOn "2016-02-19" NP957978.RAqYgSYJhk-T9A4ihZHkmggeE1BHJ5gF7nY-eti-NK0zc130_provenance.